EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Oxford Cannabinoid Technologies Holdings's Enterprise Value is €1.75 Mil.
Oxford Cannabinoid Technologies Holdings's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was €-5.58 Mil. Therefore, Oxford Cannabinoid Technologies Holdings's EV-to-EBIT for today is -0.31.
The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's EV-to-EBIT or its related term are showing as below:
FRA:0CB'
s EV-to-EBIT Range Over the Past 10 Years
Min: -4.07 Med: 0 Max: 1.94
Current: -0.31
During the past 5 years, the highest EV-to-EBIT of Oxford Cannabinoid Technologies Holdings was 1.94. The lowest was -4.07. And the median was 0.00.
FRA:0CB's EV-to-EBIT is ranked worse than 100% of 444
companies
in the Biotechnology industry
Industry Median: 8.325
vs FRA:0CB: -0.31
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Oxford Cannabinoid Technologies Holdings's Enterprise Value for the quarter that ended in Oct. 2023 was €0.61 Mil.
Oxford Cannabinoid Technologies Holdings's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was €-5.58 Mil. Oxford Cannabinoid Technologies Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -910.04%.
Oxford Cannabinoid Technologies Holdings EV-to-EBIT Historical Data
The historical data trend for Oxford Cannabinoid Technologies Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Oxford Cannabinoid Technologies Holdings Annual Data
Trend
May18
May19
May20
May21
Apr23
EV-to-EBIT
-
-
-
-7.26
-1.63
Oxford Cannabinoid Technologies Holdings Semi-Annual Data
For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Cannabinoid Technologies Holdings EV-to-EBIT Distribution
For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's EV-to-EBIT falls into.
Oxford Cannabinoid Technologies Holdings's current Enterprise Value is €1.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford Cannabinoid Technologies Holdings's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was €-5.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Oxford Cannabinoid Technologies Holdings's Enterprise Value for the quarter that ended in Oct. 2023 was €0.61 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford Cannabinoid Technologies Holdings's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was €-5.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford Cannabinoid Technologies Holdings EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:0CB has been successfully added to your 